Cargando…
Methylene Blue for Postcardiopulmonary Bypass Vasoplegic Syndrome: A Cohort Study
BACKGROUND: Methylene blue (MB) has been used to treat refractory hypotension in a variety of settings. AIMS: We sought to determine whether MB improved blood pressure in postcardiopulmonary bypass (CPB) vasoplegic syndrome (VS) in a complex cardiac surgery population. Furthermore, to determine vari...
Autores principales: | Mazzeffi, Michael, Hammer, Benjamin, Chen, Edward, Caridi-Scheible, Mark, Ramsay, James, Paciullo, Christopher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408522/ https://www.ncbi.nlm.nih.gov/pubmed/28393777 http://dx.doi.org/10.4103/aca.ACA_237_16 |
Ejemplares similares
-
Methylene Blue For Post-Cardioplumonary Bypass Vasoplegic Syndrome
por: Pangasa, Neha, et al.
Publicado: (2017) -
Methylene Blue for Vasoplegic Syndrome Postcardiac Surgery
por: Habib, Aly Makram, et al.
Publicado: (2018) -
Use of Intravenous Hydroxocobalamin without Methylene Blue for Refractory Vasoplegic Syndrome After Cardiopulmonary Bypass
por: Peyko, Vincent, et al.
Publicado: (2021) -
Twenty years of vasoplegic syndrome treatment in heart surgery. Methylene
blue revised
por: Evora, Paulo Roberto Barbosa, et al.
Publicado: (2015) -
Severe Undifferentiated Vasoplegic Shock Refractory to Vasoactive Agents Treated with Methylene Blue
por: Manji, Farheen, et al.
Publicado: (2017)